Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review

Oct, 2014   |   43  Pages   |   ISBN : GDPH80379FSA   |   GlobalData   |   Format : PDF

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott India Limited (AIL), a subsidiary of Abbott Laboratories, is an Indian pharmaceutical company that discovers, develops, manufactures and markets pharmaceutical, diagnostic, and nutritional and hospital products. AIL offers both OTC and prescription drugs in various formulations including tablets, liquids, injectibles and capsules, and nutritional products including powder. The companys products cover various therapeutic areas including womens health, thyroid disorders, depression, epilepsy, sleep disorders and diabetes. AIL provides healthcare solutions through four business units: Primary Care, which offers products in the areas of pain management, gastroenterology, through brands such as Brufen, Digene, Cremaffin; Specialty Care Metaboloics and Urology, provides solutions in the areas of Thyroid, Obesity, Diabetes and Benign Prostratic Hyperplasia; Specialty Care Neuroscience, has a broad portfolio, with specialty products in the Neurology and Psychiatric segments; and Hospital Care, provides products in the field of anesthesiology and neonatology through brands such as Forane, Sevorane and Survanta. AIL is headquartered in Mumbai, India.

Abbott India Limited Key Recent Developments

Aug 28, 2014: USIBC Concludes Successful Medical Device Mission to India
Aug 14, 2014: Abbott India Reports Revenue Of INR5.3 Billion For Quarter Ended 30 June 2014
May 28, 2014: Abbott India Reports Revenue Of INR4.9 Billion For Quarter Ended 31 March 2014
Feb 08, 2014: Abbott India Reports Revenue Of Approximately INR4.9 Billion For Quarter Ended 31 December 2013
Nov 27, 2012: Abbott Labs To Revamp India Operations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Abbott India Limited - Key Facts 6
Abbott India Limited - Key Employees 7
Abbott India Limited - Key Employee Biographies 8
Abbott India Limited - Major Products and Services 9
Abbott India Limited - History 11
Abbott India Limited - Company Statement 13
Abbott India Limited - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 Company Analysis 17
Abbott India Limited - Business Description 17
Abbott India Limited - Corporate Strategy 18
Abbott India Limited - SWOT Analysis 19
SWOT Analysis - Overview 19
Abbott India Limited - Strengths 19
Strength - Extensive Product Portfolio 19
Strength - Synergy Through Abbott Laboratories 19
Strength - Partnerships and Collaborations 19
Abbott India Limited - Weaknesses 20
Weakness - Patent Infringement Lawsuits 20
Abbott India Limited - Opportunities 21
Opportunity - Focus on Product Development 21
Opportunity - Growth Prospects: Indian Pharmaceuticals Market 21
Opportunity - Rising Geriatric Population 21
Abbott India Limited - Threats 22
Threat - Stringent Government Regulations 22
Threat - Intense Competition 22
Threat - Uncertain R&D Outcomes 22
Abbott India Limited - Key Competitors 23
Section 3 Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 Companys Lifesciences Financial Deals and Alliances 29
Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 29
Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 30
Abbott India Limited, Recent Deals Summary 31
Section 5 Companys Recent Developments 32
Aug 28, 2014: USIBC Concludes Successful Medical Device Mission to India 32
Aug 14, 2014: Abbott India Reports Revenue Of INR5.3 Billion For Quarter Ended 30 June 2014 33
May 28, 2014: Abbott India Reports Revenue Of INR4.9 Billion For Quarter Ended 31 March 2014 33
Feb 08, 2014: Abbott India Reports Revenue Of Approximately INR4.9 Billion For Quarter Ended 31 December 2013 34
Dec 24, 2013: Abbott India Appoints Valentine Yien As Additional Director 34
Dec 24, 2013: Abbott India Announces Board Changes 34
Nov 07, 2013: Abbott India Announces Resignation Of Thomas Joseph Dee From Board 35
Nov 07, 2013: Abbott India Announces Resignation of Director 36
Nov 07, 2013: Abbott India Announces Change in Accounting Year 37
Nov 07, 2013: Abbott India Reports Revenue Of Approximately INR4.6 Billion For Quarter Ended 30 September 2013 38
Section 6 Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables

Abbott India Limited, Key Facts 6
Abbott India Limited, Key Employees 7
Abbott India Limited, Key Employee Biographies 8
Abbott India Limited, Major Products and Services 9
Abbott India Limited, History 11
Abbott India Limited, Other Locations 14
Abbott India Limited, Key Competitors 23
Abbott India Limited, Ratios based on current share price 24
Abbott India Limited, Annual Ratios 25
Abbott India Limited, Interim Ratios 27
Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 29
Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 30
Abbott India Limited, Recent Deals Summary 31
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

List of Figures

Abbott India Limited, Performance Chart (2010 - 2014) 26
Abbott India Limited, Ratio Charts 28
Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 29
Abbott India Limited, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 30

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Follow Us On: